Macular Degeneration
Advanced treatment for age-related macular degeneration including injections and laser therapy.
What is Macular Degeneration?
Age-Related Macular Degeneration (AMD) is a leading cause of vision loss in adults over 50. It affects the macula, the small central portion of the retina responsible for sharp, detailed central vision. While AMD doesn't lead to complete blindness, it can severely impair your ability to read, drive, and recognize faces. There are two main types: dry (atrophic) and wet (exudative).
Common Symptoms
Our Approach to Treatment
Treatments can significantly slow its progression and, in some cases, improve vision. For wet AMD, the standard of care involves anti-VEGF injections, which help reduce the number of abnormal blood vessels and control leakage. Laser therapy may also be used in specific cases. For dry AMD, management focuses on nutritional supplements (AREDS2 formula) and lifestyle modifications to slow the disease's progression. At The Retina Institute, we provide a personalized treatment plan to preserve your vision and quality of life.
Symptoms of AMD often develop gradually and without pain. They may include a blurry or distorted area in your central vision, straight lines appearing wavy, reduced brightness of colors, and difficulty adapting to low light levels. As the condition progresses, a well-defined blind spot in your central vision may develop.
AMD is closely linked to aging. The primary risk factors include being over the age of 50, a family history of the condition, smoking, and cardiovascular disease. The dry form involves the thinning of the macula and the presence of drusen (tiny yellow deposits), while the wet form is characterized by the growth of abnormal blood vessels under the retina that leak fluid or blood.